PTPRZ1-MET fusions have been found in brain tumors, such as low-grade gliomas, secondary glioblastomas arising in adults from the progression of lower-grade gliomas, and pediatric glioblastomas at a remarkably high frequency (~10%, [145]). This evidence concerns the gene MET and central nervous system cancer.